Androsta-3

Arimistane is an aromatase inhibitor sold as a supplement

Androsta-3,5-diene-7,17-dione, usually called arimistane, is a suicidal aromatase inhibitor — it binds the enzyme irreversibly, as exemestane does. This section holds 12 lines from £36 to £132, averaging near £55, sold under names like Form-XT, Arimageddon and Nolvadren XT.

It is a real mechanism, weakly expressed

The mechanism is genuine rather than invented. What differs from the pharmaceutical inhibitors in the estrogen blockers range is potency: arimistane is substantially weaker than anastrozole, letrozole or exemestane at the doses used.

Whether that is a drawback depends entirely on the situation. For someone running a mildly aromatising compound and wanting a light touch, weaker may be exactly right — over-suppressing oestrogen causes its own problems, including joint pain, poor lipids and flattened mood. For someone on a heavily aromatising compound at a substantial dose, it will not be enough.

The supplement-sector caveat

These products come from the same manufacturing sector as prohormones, where label accuracy has historically been unreliable. A blend listing arimistane alongside several other ingredients rarely states how much of each is present, so the actual dose is often unknown.

That uncertainty matters more with an aromatase inhibitor than with most things, because both too much and too little produce problems.

What it does not do

It does not address prolactin, which is a separate pathway. It does not act as a SERM — it reduces oestrogen production rather than blocking the receptor, so it is not the tool for established gynecomastia. And it does not restore the natural axis, whatever the “PCT support” framing on some packaging suggests.

A genuine post cycle therapy protocol uses compounds with evidence for that specific job.

Where the appeal actually lies

Availability without a prescription, mostly. Anastrozole and letrozole are prescription medicines; arimistane is sold as a supplement, which is why it exists as a category at all rather than because it does something the pharmaceutical inhibitors cannot.

Signs oestrogen is too low

Aching joints, flat mood, reduced libido and poor recovery are the usual indicators, and they get misread as needing more suppression rather than less. Oestrogen is necessary in men, and crushing it produces a worse outcome than mildly elevated levels do.

Frequently asked questions

Is arimistane a real aromatase inhibitor?
Yes, a suicidal one that binds the enzyme irreversibly. It is simply much weaker than the pharmaceutical versions.

Is weaker a bad thing?
Not always. Over-suppressing oestrogen causes joint pain, poor lipids and low mood. For light control it can suit.

Can it replace anastrozole?
Not on a heavily aromatising compound at a substantial dose. It is not potent enough for that.

Do I know how much I am getting?
Often not. Blends rarely state individual ingredient doses, which matters more here than elsewhere.

Is it useful for PCT?
No. Lowering oestrogen is not the same as restarting the natural axis.